Loring Wolcott & Coolidge Fiduciary Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-32
| Closed | -$3K | – | 774 |
|
|
2021
Q2 | $3K | Buy |
+32
| New | +$3K | ﹤0.01% | 780 |
|
|
2021
Q1 | – | Sell |
-18
| Closed | -$2K | – | 357 |
|
|
2020
Q4 | $2K | Buy |
+18
| New | +$2K | ﹤0.01% | 739 |
|
|
2017
Q2 | – | Sell |
-1,100
| Closed | -$97K | – | 637 |
|
|
2017
Q1 | $97K | Hold |
1,100
| – | – | ﹤0.01% | 352 |
|
|
2016
Q4 | $91K | Hold |
1,100
| – | – | ﹤0.01% | 341 |
|
|
2016
Q3 | $102K | Hold |
1,100
| – | – | ﹤0.01% | 330 |
|
|
2016
Q2 | $86K | Hold |
1,100
| – | – | ﹤0.01% | 336 |
|
|
2016
Q1 | $91K | Hold |
1,100
| – | – | ﹤0.01% | 322 |
|
|
2015
Q4 | $115K | Hold |
1,100
| – | – | ﹤0.01% | 326 |
|
|
2015
Q3 | $150K | Hold |
1,100
| – | – | ﹤0.01% | 307 |
|
|
2015
Q2 | $150K | Hold |
1,100
| – | – | ﹤0.01% | 307 |
|
|
2015
Q1 | $137K | Hold |
1,100
| – | – | ﹤0.01% | 330 |
|
|
2014
Q4 | $99K | Hold |
1,100
| – | – | ﹤0.01% | 362 |
|
|
2014
Q3 | $79K | Hold |
1,100
| – | – | ﹤0.01% | 365 |
|
|
2014
Q2 | $68K | Hold |
1,100
| – | – | ﹤0.01% | 398 |
|
|
2014
Q1 | $75K | Hold |
1,100
| – | – | ﹤0.01% | 371 |
|
|
2013
Q4 | $77K | Buy |
+1,100
| New | +$77K | ﹤0.01% | 357 |
|